These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36789030)

  • 41. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
    Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
    JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes Among Mechanically Ventilated Patients With Severe Pneumonia and Acute Hypoxemic Respiratory Failure From SARS-CoV-2 and Other Etiologies.
    Nolley EP; Sahetya SK; Hochberg CH; Hossen S; Hager DN; Brower RG; Stuart EA; Checkley W
    JAMA Netw Open; 2023 Jan; 6(1):e2250401. PubMed ID: 36626168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-Dose Methylprednisolone Pulses for 3 Days vs. Low-Dose Dexamethasone for 10 Days in Severe, Non-Critical COVID-19: A Retrospective Propensity Score Matched Analysis.
    Mora-Luján JM; Tuells M; Montero A; Formiga F; Homs NA; Albà-Albalate J; Corbella X; Rubio-Rivas M
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Guo J; Zhou B; Zhu M; Yuan Y; Wang Q; Zhou H; Wang X; Lv T; Li S; Liu P; Yang Y; He P; Zhang P
    Epidemiol Infect; 2020 Oct; 148():e241. PubMed ID: 32998791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
    Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Corticosteroid therapy for patients with severe novel Coronavirus disease 2019.
    Ma Q; Qi D; Deng XY; Yuan GD; Tian WG; Cui Y; Yan XF; Wang DX
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8194-8201. PubMed ID: 32767349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical features predicting mortality risk in older patients with COVID-19.
    Zhou J; Huang L; Chen J; Yuan X; Shen Q; Dong S; Cheng B; Guo TM
    Curr Med Res Opin; 2020 Nov; 36(11):1753-1759. PubMed ID: 32945707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Characteristics of Patients with Severe and Critical COVID-19 in Wuhan: A Single-Center, Retrospective Study.
    Chen Z; Hu J; Liu L; Zhang Y; Liu D; Xiong M; Zhao Y; Chen K; Wang YM
    Infect Dis Ther; 2021 Mar; 10(1):421-438. PubMed ID: 33481202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
    Mikulska M; Nicolini LA; Signori A; Di Biagio A; Sepulcri C; Russo C; Dettori S; Berruti M; Sormani MP; Giacobbe DR; Vena A; De Maria A; Dentone C; Taramasso L; Mirabella M; Magnasco L; Mora S; Delfino E; Toscanini F; Balletto E; Alessandrini AI; Baldi F; Briano F; Camera M; Dodi F; Ferrazin A; Labate L; Mazzarello G; Pincino R; Portunato F; Tutino S; Barisione E; Bruzzone B; Orsi A; Schenone E; Rosseti N; Sasso E; Da Rin G; Pelosi P; Beltramini S; Giacomini M; Icardi G; Gratarola A; Bassetti M
    PLoS One; 2020; 15(8):e0237831. PubMed ID: 32817707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of vaccination status on the disease severity of patients with coronavirus disease 2019].
    Wu X; Yang Z; Zheng Y; Han W; Yu J; Zhao J; Zheng R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Sep; 34(9):915-920. PubMed ID: 36377443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of clinical characteristics and hospital mortality in critically ill patients without COVID-19 before and during the COVID-19 pandemic: a multicenter, retrospective, propensity score-matched study.
    Kim S; Choi H; Sim JK; Jung WJ; Lee YS; Kim JH
    Ann Intensive Care; 2022 Jun; 12(1):57. PubMed ID: 35731291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Epidemiological characteristics and outcome analysis of 266 patients with inhalation injuries combined with total burn area less than 30% total body surface area].
    Jiang Y; Wang KA; Wang BL; Hu LY; Zhu BH; Wu GS; Sun Y; Xia ZF
    Zhonghua Shao Shang Za Zhi; 2021 Apr; 37(4):340-349. PubMed ID: 33887882
    [No Abstract]   [Full Text] [Related]  

  • 56. Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan.
    Pya Y; Bekbossynova M; Gaipov A; Lesbekov T; Kapyshev T; Kuanyshbek A; Tauekelova A; Litvinova L; Sailybayeva A; Vakhrushev I; Sarria-Santamera A
    PLoS One; 2021; 16(12):e0261272. PubMed ID: 34936681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study.
    Chen Q; Song Y; Wang L; Zhang Y; Han L; Liu J; Yang M; Ma J; Wang T
    Expert Rev Respir Med; 2021 Apr; 15(4):543-552. PubMed ID: 33249945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.